ABSTRACT
The incidence of anxiety, mood, substance abuse disorders and schizophrenia increases during adolescence. Epidemiological evidence confirms that exposure to stress during sensitive periods of development can create vulnerabilities that put genetically predisposed individuals at increased risk for psychiatric disorders. Neuregulin 1 (NRG1) is a frequently identified schizophrenia susceptibility gene that has also been associated with the psychotic features of bipolar disorder. Previously, we established that Type II NRG1 is expressed in the hypothalamic-pituitary-adrenal (HPA) axis neurocircuitry. We also found, using a line of Nrg1 hypomorphic rats (Nrg1(Tn)), that genetic disruption of Type II NRG1 results in altered HPA axis function and environmental reactivity. The present studies used the Nrg1(Tn) rats to test whether Type II NRG1 gene disruption and chronic stress exposure during adolescence interact to alter adult anxiety- and fear-related behaviors. Male and female Nrg1(Tn) and wild-type rats were exposed to chronic variable stress (CVS) during mid-adolescence and then tested for anxiety-like behavior, cued fear conditioning and basal corticosterone secretion in adulthood. The disruption of Type II NRG1 alone significantly impacts rat anxiety-related behavior by reversing normal sex-related differences and impairs the ability to acquire cued fear conditioning. Sex-specific interactions between genotype and adolescent stress also were identified such that CVS-treated wild-type females exhibited a slight reduction in anxiety-like behavior and basal corticosterone, while CVS-treated Nrg1(Tn) females exhibited a significant increase in cued fear extinction. These studies confirm the importance of Type II NRG1 in anxiety and fear behaviors and point to adolescence as a time when stressful experiences can shape adult behavior and HPA axis function.
Subject(s)
Anxiety/genetics , Anxiety/metabolism , Fear/physiology , Neuregulin-1/deficiency , Neuregulin-1/genetics , Adrenal Glands/physiology , Age Factors , Animals , Anxiety/psychology , Chronic Disease , Fear/psychology , Female , Hypothalamus/physiology , Male , Pituitary Gland/physiology , Rats , Rats, Inbred F344 , Rats, TransgenicABSTRACT
BACKGROUND: Psychiatric illness and anxiety disorders have strong neurodevelopmental components. Environmental insults such as prenatal exposure to stress and genetic differences in stress responses may affect brain development. METHODS: A rat model of random variable prenatal stress was used to study the expression and processing of hippocampal brain-derived neurotrophic factor (BDNF) in the offspring of the stressed rat dams. To account for unknown genetic influences that may play a role in the outcome of this prenatal stress paradigm, three different rat strains with known differences in stress responsivity were studied: Fischer, Sprague-Dawley, and Lewis rats (n=132). RESULTS: Multiple disparities in mRNA expression levels of BDNF, and transcripts related to its processing and signaling were found in the three strains. Of the numerous splice variants transcribed from the BDNF gene, the transcript containing BDNF exon VI was most aberrant in the prenatally stressed animals. Protein levels of both uncleaved proBDNF and mature BDNF were also altered, as was intra-cellular signaling by phosphorylation of the neurotrophic tyrosine kinase receptor type 2 (NTRK2, TrkB) and mitogen-activated protein kinase (Erk 1/2). Changes were not only dependent on prenatal stress, but were also strain dependent, demonstrating the importance of genetic background. CONCLUSION: BDNF signaling provides both positive neurotrophic support for neurons and negative apoptotic effects, both of which may contribute to behavioral or neurochemical outcomes after prenatal exposure to stress. Differential processing of BDNF after prenatal stress in the three rat strains has implications for human subjects where genetic differences may protect or exacerbate the effects of an environmental stressor during fetal development.
Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Prenatal Exposure Delayed Effects/genetics , Prenatal Exposure Delayed Effects/metabolism , Signal Transduction/physiology , Stress, Psychological/metabolism , Animals , Blotting, Western , Brain-Derived Neurotrophic Factor/genetics , Female , Gene Expression , Hippocampus/metabolism , Male , Pregnancy , RNA, Messenger/analysis , Rats , Rats, Inbred F344 , Rats, Inbred Lew , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
Exposure to stress can result in an increased risk for psychiatric disorders, especially among genetically predisposed individuals. Neuregulin 1 (NRG1) is a susceptibility gene for schizophrenia and is also associated with psychotic bipolar disorder. In the rat, the neurons of the hypothalamic paraventricular nucleus show strong expression of Nrg1 mRNA. In patients with schizophrenia, a single nucleotide polymorphism in the 5' region of NRG1 interacts with psychosocial stress to affect reactivity to expressed emotion. However, there is virtually no information on the role of NRG1 in hypothalamic-pituitary-adrenal axis function, and whether the protein is expressed in the paraventricular nucleus is unknown. The present studies utilize a unique line of Nrg1 hypomorphic rats (Nrg1(Tn)) generated by gene trapping with the Sleeping Beauty transposon. We first established that the Nrg1(Tn) rats displayed reduced expression of both the mRNA and protein corresponding to the Type II NRG1 isoform. After confirming, using wild type animals, that Type II NRG1 is expressed in the neurocircuitry involved in regulating hypothalamic-pituitary-adrenal axis responses to environmental stimuli, the Nrg1(Tn) rats were then used to test the hypothesis that altered expression of Type II NRG1 disrupts stress regulation and reactivity. In support of this hypothesis, Nrg1(Tn) rats have disrupted basal and acute stress recovery corticosterone secretion, differential changes in expression of glucocorticoid receptors in the pituitary, paraventricular nucleus and hippocampus, and a failure to habituate to an open field. Together, these findings point to NRG1 as a potential novel regulator of neuroendocrine responses to stress as well as behavioral reactivity.
Subject(s)
Behavior, Animal/physiology , Environment , Hypothalamo-Hypophyseal System/metabolism , Neuregulin-1/genetics , Neuregulin-1/metabolism , Pituitary-Adrenal System/metabolism , Analysis of Variance , Animals , Animals, Newborn , Corticosterone/metabolism , Exploratory Behavior/physiology , Female , Glucocorticoids/metabolism , Habituation, Psychophysiologic/physiology , Male , Maternal Behavior/physiology , Mutation/genetics , RNA, Messenger/metabolism , Radioimmunoassay/methods , Rats , Rats, Inbred F344 , Rats, Transgenic , Receptors, Mineralocorticoid/metabolism , Restraint, Physical/methodsABSTRACT
Autism is a neurodevelopmental disorder characterized by abnormal reciprocal social interactions, communication deficits, and repetitive behaviors with restricted interests. BTBR T+tf/J (BTBR) is an inbred mouse strain that displays robust behavioral phenotypes with analogies to all three of the diagnostic symptoms of autism, including low social interactions, reduced vocalizations in social settings, and high levels of repetitive self-grooming. Autism-relevant phenotypes in BTBR offer translational tools to discover neurochemical mechanisms underlying unusual mouse behaviors relevant to symptoms of autism. Because repetitive self-grooming in mice may be a displacement behavior elevated by stressors, we investigated neuroendocrine markers of stress and behavioral reactivity to stressors in BTBR mice, as compared to C57BL/6J (B6), a standard inbred strain with high sociability. Radioimmunoassays replicated previous findings that circulating corticosterone is higher in BTBR than in B6. Higher basal glucocorticoid receptor mRNA and higher oxytocin peptide levels were detected in the brains of BTBR as compared to B6. No significant differences were detected in corticotrophin releasing factor (CRF) peptide or CRF mRNA. In response to behavioral stressors, BTBR and B6 were generally similar on behavioral tasks including stress-induced hyperthermia, elevated plus-maze, light â dark exploration, tail flick, acoustic startle and prepulse inhibition. BTBR displayed less reactivity than B6 to a noxious thermal stimulus in the hot plate, and less immobility than B6 in both the forced swim and tail suspension depression-related tasks. BTBR, therefore, exhibited lower depression-like scores than B6 on two standard tests sensitive to antidepressants, did not differ from B6 on two well-validated anxiety-like behaviors, and did not exhibit unusual stress reactivity to sensory stimuli. Our findings support the interpretation that autism-relevant social deficits, vocalizations, and repetitive behaviors are not the result of abnormal stress reactivity in the BTBR mouse model of autism.
Subject(s)
Autistic Disorder/metabolism , Autistic Disorder/physiopathology , Corticotropin-Releasing Hormone/metabolism , Receptors, Glucocorticoid/metabolism , Stress, Psychological/etiology , Adaptation, Ocular/genetics , Adaptation, Ocular/physiology , Animals , Autistic Disorder/genetics , Autistic Disorder/pathology , Corticosterone/metabolism , Corticotropin-Releasing Hormone/genetics , Disease Models, Animal , Fever/etiology , Hindlimb Suspension/physiology , Interpersonal Relations , Maze Learning/physiology , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Oxytocin/metabolism , Pain Threshold/physiology , RNA, Messenger/metabolism , Radioimmunoassay , Receptors, Glucocorticoid/genetics , Reflex, Acoustic/physiology , Stress, Psychological/geneticsABSTRACT
Hypoglycaemia induced by insulin injection is a powerful stimulus to the hypothalamic-pituitary-adrenal (HPA) axis and drives the secretion of corticotropin-releasing hormone and vasopressin from the neurones in the paraventricular nucleus (PVN), as well as the downstream hormones, adrenocorticotropic hormone and corticosterone. In some brain regions, hypoglycaemia also provokes increases in extracellular fluid concentrations of glutamate. Regulation of glutamatergic mechanisms could be involved in the control of the HPA axis during hypoglycaemic stress and one potential site of regulation might be at the receptors for glutamate, which are expressed in the PVN. Insulin (2.0 IU/kg, i.p.) or saline was administered to adult male Sprague-Dawley rats and the animals were sacrificed 30 min, 180 min and 24 h after injection. The amount of several kainic acid-preferring glutamate receptor mRNAs (i.e. KA2, GluR5 and GluR6) were assessed in the PVN by in situ hybridisation histochemistry. Injection of insulin induced a rapid fall in plasma glucose concentrations, which was mirrored by an increase in plasma corticosterone concentrations. KA2 and GluR5 mRNAs are highly expressed within the rat PVN, and responded to hypoglycaemia with robust increases in expression that endured beyond the period of hypoglycaemia itself. However, GluR6 mRNA is expressed in the areas adjacent to the PVN and hypoglycaemic stress failed to alter expression of this mRNA. These experiments suggest that kainic acid-preferring glutamate receptors are responsive to changes in plasma glucose concentrations and may participate in the activation of the PVN neurones during hypoglycaemic stress.
Subject(s)
Hypoglycemia/physiopathology , Paraventricular Hypothalamic Nucleus/physiology , Receptors, Kainic Acid/genetics , Animals , Blood Glucose , Corticosterone/blood , Gene Expression/physiology , Hypoglycemia/chemically induced , Hypoglycemic Agents , In Situ Hybridization , Insulin , Male , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , GluK2 Kainate ReceptorSubject(s)
Cannabis/adverse effects , Psychotic Disorders/etiology , Humans , Schizophrenia/etiologyABSTRACT
Thyroid hormone is an essential modulator of brain development, but little is known about its actions in the adult brain. Hypothyroidism is associated with gene expression changes in both central and peripheral nervous tissue. Functional consequences of adult-onset hypothyroidism include an inability to produce long-term potentiation in rat hippocampus and impaired learning and memory in both rats and man. Long-term potentiation is a form of learning that is dependent on functional N-methyl-d-aspartic acid (NMDA)-preferring ionotropic glutamate receptors. This work examines the expression of ionotropic glutamate receptor subunit mRNA following surgical thyroidectomy with or without thyroid hormone replacement. In situ hybridization histochemistry was used to determine the mRNA levels of the NMDA receptor subunits NR1, NR2A, NR2B, the AMPA receptor subunit GluR1, and the kainate receptor subunit KA2. Reducing circulating concentrations of thyroid hormone by surgical removal of the thyroid gland 2 weeks before sacrifice decreased the expression of NR1 mRNA exclusively in the hippocampus. Conversely, hyperthyroidism selectively reduced NR2B mRNA expression in the dorsal hippocampus. Altering thyroid hormone status had no effect on the expression of KA2 or GluR1 subunit mRNA. The regulation of expression of NR1 and NR2B mRNA by thyroid hormone is a novel mechanism for explaining the relationship between thyroid hormone and cognitive function.
Subject(s)
Hippocampus/physiology , Hypothyroidism/metabolism , Receptors, N-Methyl-D-Aspartate/genetics , Thyroid Hormones/metabolism , Age Factors , Animals , Gene Expression/physiology , Hypothyroidism/physiopathology , In Situ Hybridization , Male , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Receptors, AMPA/genetics , Receptors, Kainic Acid/genetics , Thyrotropin/bloodABSTRACT
Suckling increases preproTRH messenger RNA in hypothalamic paraventricular neurons (PVN) and also markedly increases TRH release during the first period of lactation. Whether lactation alters preproTRH processing resulting in the generation of novel proTRH-derived peptides that may be involved in the regulation of PRL secretion lactation is not known. Therefore, in the present study we determine whether some other peptides derived from proTRH potentially contribute to lactation-induced PRL secretion. We have recently demonstrated that two members of the family of prohormone convertases PC1 and PC2 play a significant role in proTRH processing. PC1 is the major contributor in proTRH processing, whereas PC2 may have a specific role in cleaving TRH from its extended forms. In this study, we used a recombinant vaccinia virus system to coexpress rat preproTRH complementary DNA with PC1, PC2, and the neuropeptide 7B2 in GH4C1 cells (somatomammothophs, rat). We found that two novel peptides, preproTRH(178-184) (pFQ(7)), and preproTRH(186-199) (pSE(14)), were formed after the cleavage of their precursor preproTRH(178-199) (pFE(22)) by only PC2. Their formation was confirmed by microsequence analysis. Anatomical analyses revealed that these peptides are also found in the rat PVN. In addition, we found that pFE(22), pSE(14) and pFQ(7) produced a dose-dependent release of PRL from primary cultures of pituitary cells compared with one of the well studied secretagogues of PRL, TRH. To establish whether these peptides might play a role in vivo in the regulation of PRL release, we took rat litters on postnatal day 4, separated the pups from their mothers for 6 h, and then reunited the pups and mothers for 45 min. At the end of this period, the mothers were killed, acidic extracts of microdissected PVN were prepared and subjected to SDS-PAGE, followed by slicing and analysis by pFE(22) RIA. Forty-five minutes of suckling induced a marked 6-fold increase in serum levels of PRL. In addition, PVN levels of pFE(22) and pSE(14) increased approximately 5-fold during the same period in the acutely suckling females. Lactating animals that were separated from their litters and never reunited with their pups had low levels of PRL, and pFE(22) and pSE(14). These data provide the first evidence for alterations in proTRH processing in the PVN during lactation and suggest that the products of this altered processing may play a physiological role in the regulation of PRL secretion.
Subject(s)
Lactation/physiology , Paraventricular Hypothalamic Nucleus/metabolism , Peptide Fragments/metabolism , Proprotein Convertase 1 , Protein Precursors/metabolism , Thyrotropin-Releasing Hormone/metabolism , Animals , Aspartic Acid Endopeptidases/physiology , Cells, Cultured , Female , Mice , Neurons/metabolism , Paraventricular Hypothalamic Nucleus/cytology , Proprotein Convertase 2 , Proprotein Convertases , Rats , Rats, Sprague-Dawley , Subtilisins/physiologyABSTRACT
Lipopolysaccharide (LPS) is known to raise the concentration of the circulating stress hormones such as ACTH, corticosterone and beta-endorphin. This effect of endotoxin is mediated by different immune system-released hormone-like factors (e.g. interleukins, tumor necrosis factor etc.). Gamma-ray irradiation of LPS alters its biological properties and results in a radiodetoxified LPS preparation with numerous beneficial effects and decreased toxicity. In this study we compared the neuroendocrine effects of a commercial LPS and our native and radiodetoxified LPS preparations in rats. Plasma ACTH, corticosterone and beta-endorphin levels were measured by specific radioimmunoassays 120 min after intraperitoneal LPS administration. Control animals were injected with saline. Results show a dramatic increase in all hormones after administration of commercial and our native LPS preparation. Hormone levels in saline-injected controls and radiodetoxified LPS-treated rats did not rise significantly. These results suggest that radio-detoxification disintegrated that part of the LPS molecule complex which is responsible for toxicity including an enhanced production of cytokines, which trigger the hypothalamo-pituitary-adrenal axis.
Subject(s)
Hypothalamo-Hypophyseal System/immunology , Lipopolysaccharides/immunology , Lipopolysaccharides/radiation effects , Pituitary-Adrenal System/immunology , Adrenocorticotropic Hormone/blood , Animals , Corticosterone/blood , Gamma Rays , Male , Rats , Rats, Wistar , beta-Endorphin/bloodABSTRACT
Recent evidence suggests that galanin may regulate prolactin (PRL) secretion during lactation. In this article, we describe the regulation of anterior pituitary galanin and PRL gene expression during pregnancy and after parturition in the rat. Expression of galanin and PRL in the anterior pituitary were significantly higher at d 20 of pregnancy compared to diestrus. One day after parturition, galanin mRNA levels increased a further 4.5-fold. This post partum increase in gene expression was not observed for PRL. The increase in galanin gene expression was maintained above the diestrous level for at least 10 d after parturition. PRL mRNA expression, on the other hand, was largely unchanged after parturition. Although the increase in galanin gene expression 1 d after parturition was independent of suckling, subsequently, galanin gene expression was significantly higher in nursing mothers. Anterior pituitary galanin gene expression was 12-fold higher in nursing mothers compared with those that were not, 3 d after parturition. Similarly, PRL gene expression was significantly lower in mothers who were not suckling their pups 3 d after parturition. Initiation of suckling alone was insufficient to stimulate galanin and PRL expression. Despite suckling for 2 d, removal of the suckling stimulus subsequently resulted in a rapid decrease in galanin gene expression. Hence, the stimulatory effect of suckling on galanin expression requires a sustained suckling stimulus. In conclusion, the data support the hypothesis that anterior pituitary galanin plays an important role during lactation, likely acting to amplify lactotroph stimulation through paracrine and autocrine mechanisms.
Subject(s)
Animals, Suckling/physiology , Galanin/genetics , Gene Expression Regulation , Pituitary Gland, Anterior/metabolism , Prolactin/genetics , Aging , Animals , Diestrus , Female , Postpartum Period , Pregnancy , RNA, Messenger/metabolism , Rats , Rats, Sprague-DawleyABSTRACT
The recent American Endocrine Society Annual Workshop was attended by over 125 students, senior investigators and Fellows. The workshop focused on the latest developments in central nervous system (CNS) mechanisms (mainly peptidergic) that influence food intake and energy expenditure, and the biological consequences of altered energy states on reproduction.
ABSTRACT
Leptin is an important hormone that has potent effects on appetite and body weight. The regulation of leptin gene expression and secretion by corticosteroids and insulin was studied in the rat. Adrenalectomy resulted in a significant reduction in leptin gene expression and secretion. The reduction was corrected by hormonal replacement with corticosterone pellets, showing that normal levels of circulating corticosteroids are required to maintain leptin expression and secretion in the body. Chronic treatment with dexamethasone (DEX) over 3 wk did not significantly increase leptin gene expression and secretion, contrary to earlier reports using shorter treatment paradigms. The profound weight loss associated with chronic DEX treatment may have abrogated the direct stimulatory effect of DEX on leptin gene expression and secretion, indicating a possible crosstalk between corticosteroids and leptin in the regulation of body weight. Shorter-term treatment of animals with DEX (3.7 micrograms/g body wt; 24 h) increased leptin gene expression and secretion about 2-fold and 1.4-fold, respectively. The increase was independent of circulating insulin concentrations. In streptozotocin-treated rats, short-term DEX treatment increased leptin gene expression and secretion about 3.5-fold and 2-fold, respectively. The data indicate that circulating leptin concentrations and adipose tissue leptin expression are dependent on corticosteroids and insulin. Although acute DEX treatment resulted in a stimulatory effect on leptin secretion and expression, chronic DEX treatment did not. The stimulatory effect of DEX on leptin is independent of circulating insulin concentrations.
Subject(s)
Adrenal Cortex Hormones/pharmacology , Gene Expression Regulation/drug effects , Insulin/pharmacology , Proteins/genetics , Proteins/metabolism , Adipose Tissue/metabolism , Adrenalectomy , Animals , Corticosterone/blood , Corticosterone/pharmacology , Dexamethasone/administration & dosage , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Leptin , Male , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Streptozocin/pharmacologyABSTRACT
Obese (Lep) gene expression and leptin secretion are regulated by changes in food intake. However, the mechanism by which leptin concentrations are altered by fasting and feeding is unclear. Since these changes occur in parallel with changes in plasma insulin, it is possible that the changes observed are mediated by insulin. To test this hypothesis, we studied the role of insulin in the regulation of Lep gene expression in epididymal fat and leptin secretion during feeding. As shown previously, fasted animals showed significant reductions in Lep mRNA, plasma leptin, and plasma insulin concentrations. Conversely, feeding increased plasma insulin, Lep mRNA, and plasma leptin. In streptozotocin (STZ)-treated animals, plasma insulin concentrations were low. This was associated with low Lep mRNA and plasma leptin concentrations. Changes in food intake, whether fasting or feeding, did not significantly alter plasma insulin levels in STZ-treated animals. Under these circumstances, Lep mRNA and plasma leptin concentrations also remained low. Our results demonstrate that the decrease in Lep mRNA and plasma leptin during fasting and the increase with feeding are dependent on changes in the plasma insulin concentration.
Subject(s)
Food , Insulin/blood , Obesity/blood , Proteins/genetics , RNA, Messenger/metabolism , Animal Feed , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Blood Glucose/drug effects , Blood Glucose/metabolism , Body Weight/drug effects , Body Weight/physiology , Data Interpretation, Statistical , Energy Intake/drug effects , Energy Intake/physiology , Gene Expression/drug effects , Leptin , Male , Obesity/genetics , Proteins/drug effects , Proteins/metabolism , RNA, Messenger/drug effects , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Streptozocin/administration & dosage , Streptozocin/pharmacologyABSTRACT
Immunoreactive (ir-) adrenocorticotropic hormone (ACTH) and beta-endorphin (beta E) levels were determined in seven brain regions, in the three pituitary lobes, and in the plasma of the domestic gander by specific radioimmunoassays. In the brain regions studied the relative concentrations of ir-ACTH and ir-beta E were the highest in the mediobasal hypothalamus and in the paraventricular nucleus. There were lower levels of these peptides in the supraoptic nucleus, in the septum, and in the dorsal thalamus. Very low ir-ACTH and -beta E contents were found in the archistriatum and in the lobus parolfactorius. In the pars distalis of the pituitary gland the cephalic lobe contained about 10 times more ir-ACTH (3596 pmol/lobe) and 4 times more ir-beta E (867 pmol/ lobe) than the caudal lobe (383 pmol/lobe and 189 pmol/lobe, respectively). Sephadex G-50 chromatography of pooled cephalic and caudal lobe extracts resulted in two distinct ir-beta E peaks, with elution volumes corresponding to the mammalian beta-lipotropin and beta E, and three ir-ACTH peaks, the second one coeluting with mammalian ACTH. In the neural lobe the ir-ACTH/-beta E concentrations were similar to those in the hypothalamus. Resting plasma ir-ACTH (12.8 +/- 1.47 pmol/ml) but not ir-beta E (31.4 +/- 1.22 pmol/ml) levels were significantly increased following castration (to 41.4 +/- 1.11 pmol/ml). Serial blood sampling indicated pulsatile ir-beta E secretion (mean, coefficients of variation, and minimum-maximum range: 17.5, 62.78, and 2.9-49.7, respectively, for gander 1 and 23.3, 62.85, and 5.00-61.5, respectively, for gander 2).
Subject(s)
Adrenocorticotropic Hormone/analysis , Brain Chemistry/physiology , Geese/physiology , Pituitary Gland/chemistry , beta-Endorphin/analysis , Adrenocorticotropic Hormone/blood , Animals , Chromatography, Gel , Geese/blood , Humans , Immune Sera/immunology , Male , Orchiectomy , Rabbits , Radioimmunoassay , beta-Endorphin/blood , beta-Endorphin/metabolismABSTRACT
The responsiveness of the POMC system to exogenous stimuli and the diurnal and seasonal rhythmicity of ACTH and beta-endorphin (beta E) in plasma were studied in outdoor-reared domestic ganders. Plasma levels of ACTH- and beta E-like immunoreactivities were determined by direct and specific radioimmunoassays. In the first series of experiments immunoreactive (ir) ACTH and beta E were measured in the plasma of male domestic geese after 5 min of ether stress and after administration of 2 micrograms/kg lipopolysaccharide (LPS). Both ir-ACTH and ir-beta E levels increased 5 and 10 min after ether inhalation, but the increase in the ir-beta E concentration was only half that of the ir-ACTH. The plasma ir-ACTH levels were elevated after 60 and 120 min but not after 90 min of LPS administration: ir-beta E levels were unchanged at all time points. In a second series of experiments blood samples were taken on 30 March. 16 June, 4 August, and 27 October. On these days diurnal samplings were performed at 02:00, 06:00, 10:00, 14:00, 18:00, and 22:00 h. A two-way analysis of variance showed significant diurnal and seasonal changes for both hormones and significant interaction between the diurnal and seasonal levels. The highest daily mean values of the plasma ir-ACTH and ir-beta E concentrations were measured in June. The maximum of the ir-ACTH level was at 10:00 h in March and August, but at 22:00 h in June and October. The changes in ir-beta E concentrations paralleled those of ir-ACTH, but the changes did not reach statistical significance in every case.
Subject(s)
Adrenocorticotropic Hormone/blood , Circadian Rhythm/physiology , Geese/blood , Seasons , beta-Endorphin/blood , Administration, Inhalation , Adrenocorticotropic Hormone/metabolism , Animals , Ether/administration & dosage , Ether/toxicity , Geese/metabolism , Immune Sera/immunology , Injections, Intravenous/veterinary , Lipopolysaccharides/administration & dosage , Lipopolysaccharides/toxicity , Male , Poultry Diseases/chemically induced , Poultry Diseases/metabolism , Rabbits , Radioimmunoassay/veterinary , Stress, Physiological/chemically induced , Stress, Physiological/metabolism , Stress, Physiological/veterinary , Time Factors , beta-Endorphin/metabolismABSTRACT
To evaluate the relative weight of the ACTH-ergic and beta-endorphin-ergic pathway(s) leaving the medial hypothalamus (MH) in anterior or posterior directions immunoreactive ACTH and beta-endorphin (ir-ACTH and ir-betaE) were quantified in selected brain regions of the rat 7-8 days after placing anterolateral (ALC) or posterolateral (PLC) cut around the MH. Retrograde accumulation of both peptides was observed in the MH after ALC, but not after PLC. ALC resulted in dramatic decrease in ir-ACTH/ir-betaE concentrations in all extra-MH brain regions tested (extra-MH hypothalamus, septum, thalamus, hippocampus, amygdala, and medulla oblongata). In contrast, ir-ACTH and ir-betaE levels decreased only in the thalamus and in the medulla oblongata after PLC. The present data indicate (a) ACTH- and betaE-like substances synthesized in the arcuate region of the hypothalamus are axonally transported to extrahypothalamic brain regions by neuronal pathways leaving the MH primarily anterolateral, anterodorsal, or anteromedial direction (even the fibers of certain posteromedial or posterolateral projections leave the MH some anterior directions); (b) the posterior ACTH-/betaE-ergic projections seem to be of minor importance except for the thalamus and the medulla oblongata where it contributes to about one-third of the peptide content. Our biochemical study provide quantitative complementary data to the detailed immunohistochemical picture of the ACTH/betaE-ergic projections in the rat brain described by Khachaturian et al.
Subject(s)
Adrenocorticotropic Hormone/metabolism , Brain/metabolism , Hypothalamus, Middle/physiology , beta-Endorphin/metabolism , Amygdala/metabolism , Animals , Hippocampus/metabolism , Hypothalamus/metabolism , Male , Medulla Oblongata/metabolism , Organ Specificity , Rats , Rats, Wistar , Thalamus/metabolismABSTRACT
The effect of acetylcholine on the neurointermediate lobe beta-endorphin secretion was studied in the neonatal and in the adult rat in vitro. Acetylcholine stimulated beta-endorphin secretion from the 2-day- and 5-day-old neurointermediate lobe, the effect was dose dependent and more pronounced in the presence of the cholinesterase inhibitor eserine. The 10-day-, the 21-day-old and the adult rat neurointermediate lobes did not respond to acetylcholine, even in the presence of eserine. Basal beta-endorphin secretion was elevated by the D2 receptor antagonist sulpiride, but acetylcholine was without effect in the 10-day-old and in the adult neurointermediate lobe even after dopamine receptor blockade. The beta-endorphin stimulatory response to acetylcholine was diminished by the M1 muscarinic receptor antagonist pirenzepine and blocked by the M3 > M1 antagonist 4-diamino-phenyl-piperidine (4-DAMP). The selective M2 antagonist methoctramine and nicotine had no effect. These data indicate that the neurointermediate lobe beta-endorphin secretion is under special muscarinic cholinergic regulation for a relatively short time after birth. The disappearance of this stimulatory cholinergic effect in later life might be due to changes in the intracellular secretory machinery in the IL and/or to the uncoupling of the cholinergic receptors from the intracellular signal transduction system(s) responsible for the stimulated secretion in the rat melanotrope cells.
Subject(s)
Aging/metabolism , Muscarinic Agonists/pharmacology , Pituitary Gland/metabolism , beta-Endorphin/metabolism , Acetylcholine/antagonists & inhibitors , Acetylcholine/pharmacology , Animals , Animals, Newborn , Female , In Vitro Techniques , Male , Muscarinic Antagonists/pharmacology , Physostigmine/pharmacology , Pituitary Gland/drug effects , Rats , Rats, WistarABSTRACT
Thyroid hormone is required for basal and estrogen-induced expression of anterior pituitary galanin. Steady-state anterior pituitary galanin mRNA levels decreased 6-fold in hypothyroid rats after 3 weeks of treatment. Similarly, hypothyroidism resulted in a 2.6-fold decrease in estrogen induction of galanin gene expression. The effect of thyroid hormone on anterior pituitary galanin gene expression appears to be exerted, at least in part, at the pituitary itself. Transient expression assays in GH3 cells suggest the involvement of transcriptional mechanisms in the regulation of galanin gene expression by thyroid hormone. A region between -41 and -132 bp upstream of the transcriptional start site confers thyroid hormone responsiveness to the galanin gene. Gel-mobility shift assays show specific binding of 'SPI-like' proteins in GH3 nuclear extracts to this region of the galanin gene. This binding was greatly enhanced by thyroid hormone.
Subject(s)
Estradiol/pharmacology , Galanin/biosynthesis , Gene Expression Regulation , Hypothyroidism/metabolism , Pituitary Gland, Anterior/metabolism , Thyroxine/pharmacology , Transcription, Genetic , Triiodothyronine/pharmacology , Animals , Base Sequence , Cell Line , Cells, Cultured , Gene Expression Regulation/drug effects , Genes, Reporter , Hypothyroidism/chemically induced , Male , Molecular Sequence Data , Pituitary Gland, Anterior/drug effects , Propylthiouracil , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley , Recombinant Fusion Proteins/biosynthesis , Regulatory Sequences, Nucleic Acid , TransfectionABSTRACT
We have previously determined that compensatory renal growth (CRG) during the initial 24-48 h after uninephrectomy (UNX) is GH independent in weanling animals, but associated with significant increases in insulin-like growth factor I (IGF-I) and IGF-I receptor gene expression. The purpose of the present study was to determine the temporal sequence of molecular and cellular events that occur at various time points (1, 6, 12, 18, 24, 48, and 72 h post-UNX) during this early period of accelerated renal growth in the weanling (21- to 25-day-old) rat. Rapid and sustained increases in steady state renal IGF-I receptor and IGF-I messenger RNA (mRNA) were observed at 1 and 6 h, respectively, and remained elevated in the remnant kidneys until 72 h post-UNX. The mRNAs for the early response genes, c-fos and c-jun, were not induced in the remnant kidneys from weanling rats until between 12-18 h, but were also sustained through 48 h post-UNX. Increases in remnant kidney DNA content and [3H]thymidine incorporation also occurred from 18-48 h post-UNX and returned to baseline levels by 72 h post-UNX, indicating that the hyperplastic response in the weanling remnant kidney occurs over a discrete period early after UNX. Neither IGF-I nor early response genes were elevated in kidneys from adult animals, which exhibited only hypertrophic renal growth at those early time points after UNX. These findings suggest that early CRG in the weanling rat is associated with rapid increases in IGF-I mRNA followed by a rise in c-fos and c-jun gene expression and a mitogenic response. Furthermore, when the mRNA levels of IGF-I and early response genes returned to baseline levels, mitogenic growth stopped, and slower prolonged hypertrophic renal growth ensued.